CNBC World

Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs

Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.

This is a short WorldPing brief. The full report was published by CNBC World.

Read the full report at CNBC World

Related news